HIGHLIGHTS
- who: . and collaborators from the Autonomous University of Nuevo Leu00f3n, Mexico have published the Article: Lower-dose corticosteroid therapy in severe immune thrombocytopenia during pregnancy: The comparable ef cacy and lower incidence of maternal complications, in the Journal: (JOURNAL)
- what: The aim of this study was to determine the safety and efficacy of low-dose prednisone therapy (defined as 0.25-0.5 mg/day) for the management of severe immune thrombocytopenia during pregnancy. It is noticed that the majority of the patients enrolled in this study had no or minor bleeding tendency before treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.